Literature DB >> 2355023

Human ceruloplasmin. Tissue-specific expression of transcripts produced by alternative splicing.

F M Yang1, W E Friedrichs, R L Cupples, M J Bonifacio, J A Sanford, W A Horton, B H Bowman.   

Abstract

Ceruloplasmin (CP) is a plasma glycoprotein that transports copper throughout the body. In previous studies (Yang, F., Naylor, S., Lum, J., Cutshaw, S., McCombs, J., Naberhaus, K., McGill, J., Adrian, G., Moore, C., Barnett, D., and Bowman, B. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 3277-3261), two CP cDNA clones, CP-1 and CP-2, from a human cDNA library, differed from each other by the presence or absence, respectively, of 12 nucleotide bases encoding a deduced sequence of Gly-Glu-Tyr-Pro near the carboxyl-terminal region of the ceruloplasmin molecule. Examination of genomic DNA demonstrates that the two CP mRNAs are produced from a single gene by alternative spliced patterns. The additional amino acids deduced in CP-1 are products of alternative splicing within an intron of the CP gene at a site 12 nucleotide bases 3' to the commonly used site of CP-2. The CP-1 mRNA transcript encoding four extra amino acids appeared as a minor species accompanying CP-2 mRNA in placenta and chondrocytes. CP-1 mRNA was the predominant CP transcript in a lymphoblastic leukemia cell line, CEM. The mRNA examined from other tissues contained only CP-2 mRNA transcripts. These findings predict that alternative RNA splicing may lead to the differential expression of CP genomic sequences and produce alternate isoforms from a single CP gene in specific tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2355023

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Caeruloplasmin biosynthesis by the human uterus.

Authors:  M L Schilsky; R J Stockert; J W Pollard
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

2.  Ceruloplasmin gene expression in the murine central nervous system.

Authors:  L W Klomp; Z S Farhangrazi; L L Dugan; J D Gitlin
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Wilson's disease: A review of what we have learned.

Authors:  Kryssia Isabel Rodriguez-Castro; Francisco Javier Hevia-Urrutia; Giacomo Carlo Sturniolo
Journal:  World J Hepatol       Date:  2015-12-18

4.  Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia.

Authors:  Seth Guller; Catalin S Buhimschi; Yula Y Ma; Se Te J Huang; Liubin Yang; Edward Kuczynski; Eduardo Zambrano; Charles J Lockwood; Irina A Buhimschi
Journal:  Lab Invest       Date:  2008-08-04       Impact factor: 5.662

5.  Aceruloplasminemia: a case report.

Authors:  Domenico Di Raimondo; Antonio Pinto; Antonino Tuttolomondo; Paola Fernandez; Clara Camaschella; Giuseppe Licata
Journal:  Intern Emerg Med       Date:  2008-04-12       Impact factor: 3.397

6.  Identification of pituitary adenylate cyclase-activating polypeptide1-38-binding factor in human plasma, as ceruloplasmin.

Authors:  J W Tams; A H Johnsen; J Fahrenkrug
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

Review 7.  A general map of iron metabolism and tissue-specific subnetworks.

Authors:  Valerie Hower; Pedro Mendes; Frank M Torti; Reinhard Laubenbacher; Steven Akman; Vladmir Shulaev; Suzy V Torti
Journal:  Mol Biosyst       Date:  2009-03-06

8.  Wilson's disease masquerading as nonalcoholic steatohepatitis.

Authors:  Sabina Mahmood; Nobu Inada; Akiyoshi Izumi; Miwa Kawanaka; Haruhiko Kobashi; Gotaro Yamada
Journal:  N Am J Med Sci       Date:  2009-07

9.  Effects of ATP7A overexpression in mice on copper transport and metabolism in lactation and gestation.

Authors:  Jarrod Wadwa; Yu-Hsiang Chu; Nhu Nguyen; Thomas Henson; Alyssa Figueroa; Roxana Llanos; Margaret Leigh Ackland; Agnes Michalczyk; Hendrik Fullriede; Grant Brennan; Julian F B Mercer; Maria C Linder
Journal:  Physiol Rep       Date:  2014-01-13

10.  Mechanism of Copper Uptake from Blood Plasma Ceruloplasmin by Mammalian Cells.

Authors:  Danny Ramos; David Mar; Michael Ishida; Rebecca Vargas; Michaella Gaite; Aaron Montgomery; Maria C Linder
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.